NDC 73069-443

Viatrexx-Prolo

Adrenal, Alpha Ketoglutaric Acid, Alpha Lipoic Acid, Apomorphine, Arnica Montana, Articulation Capsule, Ascorbic Acid, Bfgf, Bdnf, Beta Endorphin, Bryonia, Cartilage, Colchicum Automnale, Collagen, Co-q 10, Erythrocytes, Il-1, Il-3, Mesenchyme, Muscle, Nadid, Nerve, Pituitary Gland, Placenta, Quinhydrone, Tendon, Transforming Growth Factor-2, Vitamin B1, Vitamin B12, Vitamin B2, Vitamin B3, Vitamin B5, Vitamin B6, Vitamin B9, Vitamin E

Viatrexx-Prolo is a Intramuscular; Intravenous; Parenteral; Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Viatrexx Bio Incorporated. The primary component is Sus Scrofa Adrenal Gland; Bos Taurus Adrenal Gland; .alpha.-ketoglutaric Acid; .alpha.-lipoic Acid; Apomorphine; Arnica Montana; Bos Taurus Joint Capsule; Ascorbic Acid; Basic Fibroblast Growth Factor (human); Brain-derived Neurotrophic Factor Human; Sus Scrofa Joint Capsule; Beta-endorphin Human; Bryonia Alba Root; Sus Scrofa Cartilage; Bos Taurus Cartilage; Colchicum Autumnale Flower; Pork Collagen; Interleukin-1 .beta. Human; Interleukin-1.alpha.; Bos Taurus Mesenchyme; Sus Scrofa Mesenchyme; Interleukin-3; Pork; Beef; Nadide; Sus Scrofa Nerve; Bos Taurus Nerve; Bos Taurus Pituitary Gland; Sus Scrofa Pituitary Gland; Bos Taurus Placenta; Sus Scrofa Placenta; Quinhydrone; Sus Scrofa Tendon; Bos Taurus Tendon; Cetermin; Thiamine; Ubidecarenone; Cyanocobalamin; Riboflavin; Niacin; Pantothenic Acid; Pyridoxine; Folic Acid; .alpha.-tocopherol Succinate, D-.

Product ID	73069-443_bd5ff266-9342-451b-b00f-bbcc331b588c
NDC	73069-443
Product Type	Human Prescription Drug
Proprietary Name	Viatrexx-Prolo
Generic Name	Adrenal, Alpha Ketoglutaric Acid, Alpha Lipoic Acid, Apomorphine, Arnica Montana, Articulation Capsule, Ascorbic Acid, Bfgf, Bdnf, Beta Endorphin, Bryonia, Cartilage, Colchicum Automnale, Collagen, Co-q 10, Erythrocytes, Il-1, Il-3, Mesenchyme, Muscle, Nadid, Nerve, Pituitary Gland, Placenta, Quinhydrone, Tendon, Transforming Growth Factor-2, Vitamin B1, Vitamin B12, Vitamin B2, Vitamin B3, Vitamin B5, Vitamin B6, Vitamin B9, Vitamin E
Dosage Form	Injection
Route of Administration	INTRAMUSCULAR; INTRAVENOUS; PARENTERAL; SUBCUTANEOUS
Marketing Start Date	2019-03-29
Marketing Category	UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler Name	VIATREXX BIO INCORPORATED
Substance Name	SUS SCROFA ADRENAL GLAND; BOS TAURUS ADRENAL GLAND; .ALPHA.-KETOGLUTARIC ACID; .ALPHA.-LIPOIC ACID; APOMORPHINE; ARNICA MONTANA; BOS TAURUS JOINT CAPSULE; ASCORBIC ACID; BASIC FIBROBLAST GROWTH FACTOR (HUMAN); BRAIN-DERIVED NEUROTROPHIC FACTOR HUMAN; SUS SCROFA JOINT CAPSULE; BETA-ENDORPHIN HUMAN; BRYONIA ALBA ROOT; SUS SCROFA CARTILAGE; BOS TAURUS CARTILAGE; COLCHICUM AUTUMNALE FLOWER; PORK COLLAGEN; INTERLEUKIN-1 .BETA. HUMAN; INTERLEUKIN-1.ALPHA.; BOS TAURUS MESENCHYME; SUS SCROFA MESENCHYME; INTERLEUKIN-3; PORK; BEEF; NADIDE; SUS SCROFA NERVE; BOS TAURUS NERVE; BOS TAURUS PITUITARY GLAND; SUS SCROFA PITUITARY GLAND; BOS TAURUS PLACENTA; SUS SCROFA PLACENTA; QUINHYDRONE; SUS SCROFA TENDON; BOS TAURUS TENDON; CETERMIN; THIAMINE; UBIDECARENONE; CYANOCOBALAMIN; RIBOFLAVIN; NIACIN; PANTOTHENIC ACID; PYRIDOXINE; FOLIC ACID; .ALPHA.-TOCOPHEROL SUCCINATE, D-
Active Ingredient Strength	201 [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL
Pharm Classes	Dopamine Agonists [MoA],Dopaminergic Agonist [EPC],Vitamin C [EPC],Ascorbic Acid [CS],Non-Standardized Food Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [CS],Dietary Proteins [CS],Meat Proteins [EXT],Non-Standardized Food Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [CS],Dietary Proteins [CS],Meat Proteins [EXT],Vitamin B 12 [CS],Vitamin B12 [EPC],Nicotinic Acid [EPC],Nicotinic Acids [CS],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient]
NDC Exclude Flag	N
Listing Certified Through	2020-12-31

Packaging

NDC 73069-443-13

5 VIAL, MULTI-DOSE in 1 BOX (73069-443-13) > 1 mL in 1 VIAL, MULTI-DOSE

Marketing Start Date	2019-05-06
NDC Exclude Flag	N
Sample Package?	N

NDC SPL Data Element Entries

NDC 73069-443-87 [73069044387]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-34 [73069044334]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-52 [73069044352]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-65 [73069044365]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-76 [73069044376]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-45 [73069044345]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-42 [73069044342]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-05

NDC 73069-443-72 [73069044372]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-19 [73069044319]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-73 [73069044373]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-58 [73069044358]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-83 [73069044383]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-64 [73069044364]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-54 [73069044354]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-37 [73069044337]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-68 [73069044368]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-25 [73069044325]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-55 [73069044355]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-15 [73069044315]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-84 [73069044384]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-22 [73069044322]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-27 [73069044327]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-11 [73069044311]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-67 [73069044367]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-49 [73069044349]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-13 [73069044313]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-85 [73069044385]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-29 [73069044329]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-88 [73069044388]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-43 [73069044343]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-86 [73069044386]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-47 [73069044347]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-89 [73069044389]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-78 [73069044378]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-63 [73069044363]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-46 [73069044346]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-05

NDC 73069-443-33 [73069044333]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-26 [73069044326]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-62 [73069044362]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-36 [73069044336]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-56 [73069044356]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-23 [73069044323]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-41 [73069044341]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-05

NDC 73069-443-74 [73069044374]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-51 [73069044351]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-28 [73069044328]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-57 [73069044357]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-31 [73069044331]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-38 [73069044338]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-66 [73069044366]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-17 [73069044317]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-14 [73069044314]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-39 [73069044339]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-24 [73069044324]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-16 [73069044316]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-71 [73069044371]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-61 [73069044361]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-35 [73069044335]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-77 [73069044377]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-59 [73069044359]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-18 [73069044318]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-32 [73069044332]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-44 [73069044344]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-05

NDC 73069-443-75 [73069044375]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-12 [73069044312]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-53 [73069044353]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-69 [73069044369]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-79 [73069044379]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-48 [73069044348]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-81 [73069044381]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-21 [73069044321]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

NDC 73069-443-82 [73069044382]

Viatrexx-Prolo INJECTION

Marketing Category	unapproved drug other
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	2019-05-06

SPL SET ID:	744a3833-e610-4840-8602-4532a410c1c3
Manufacturer	VIATREXX BIO INCORPORATED
UNII	I8442U2G7J T7J046YI2B 693Y43MXY4 O80TY208ZW 4PIB2155QP 83AL37E3A7 3S51P4W3XQ 0470X06FYR UH52A16DZB S3529G9M9V N21FAR7B4S 8ID597Z82X 935E97BOY8 2679MF687A A802907MI4 EJ27X76M46 UE77B10IIY 19F5HK2737 M2776SWB29 097FL89535 LX0XHE5NLN 7JM57I419K 8666ZWZ3E1 L0PFEMQ1DT LU4B53JYVE 73ECW5WG2F P6YC3EG204 3802H34QRI C8CV8867O8 R69Y34R8KU 28G2U3MQJK TLM2976OFR 0U46U6E8UK X62226112J KV2JZ1BI6Z P4A66LQ3QJ X66NSO3N35 O138UB266J PQ6CK8PD0R 398IYQ16YV 73Y7P0K73Y 782I3O9VSM JXV50I6ZHK
PHarm Class EPC	Vitamin B6 Analog [EPC]
UPC Code	0073069443422 0073069443415
NUI Code	N0000005657 N0000175452 N0000192800